VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $7,093,000 | +39.5% | 269,700 | +439.4% | 0.07% | +51.1% |
| Q4 2015 | $5,083,000 | -85.2% | 50,000 | -74.0% | 0.04% | -90.1% |
| Q3 2015 | $34,338,000 | +56.9% | 192,500 | +95.4% | 0.45% | +54.4% |
| Q2 2015 | $21,882,000 | -78.0% | 98,500 | -85.8% | 0.29% | -78.4% |
| Q4 2014 | $99,605,000 | -30.0% | 696,000 | -35.9% | 1.36% | -40.5% |
| Q3 2014 | $142,352,000 | +12.9% | 1,085,000 | +8.5% | 2.28% | +25.5% |
| Q2 2014 | $126,120,000 | – | 1,000,000 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |